Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker PVLA
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | Jeffrey S. Martini Chief Scientific Officer | PVLA Palvella Therapeutics, Inc. | Sale | 200 | $169.78 | $34.0K Sale | Form 4 ↗ |
| Nov 11, 2026 | Jeffrey S. Martini Chief Scientific Officer | PVLA Palvella Therapeutics, Inc. | Sale | 600 | $168.73 | $101.2K Sale | Form 4 ↗ |
| Nov 11, 2026 | Jeffrey S. Martini Chief Scientific Officer | PVLA Palvella Therapeutics, Inc. | Sale | 1,200 | $167.75 | $201.3K Sale | Form 4 ↗ |
| Nov 11, 2026 | Jeffrey S. Martini Chief Scientific Officer | PVLA Palvella Therapeutics, Inc. | Sale | 1,133 | $166.76 | $188.9K Sale | Form 4 ↗ |
| Nov 11, 2026 | Jeffrey S. Martini Chief Scientific Officer | PVLA Palvella Therapeutics, Inc. | Sale | 1,467 | $165.78 | $243.2K Sale | Form 4 ↗ |
| Nov 11, 2026 | Jeffrey S. Martini Chief Scientific Officer | PVLA Palvella Therapeutics, Inc. | Sale | 1,650 | $164.14 | $270.8K Sale | Form 4 ↗ |
| Nov 10, 2026 | Jeffrey S. Martini Chief Scientific Officer | PVLA Palvella Therapeutics, Inc. | Sale | 800 | $172.12 | $137.7K Sale | Form 4 ↗ |
| Nov 10, 2026 | Jeffrey S. Martini Chief Scientific Officer | PVLA Palvella Therapeutics, Inc. | Sale | 550 | $169.03 | $93.0K Sale | Form 4 ↗ |
| Nov 10, 2026 | Jeffrey S. Martini Chief Scientific Officer | PVLA Palvella Therapeutics, Inc. | Sale | 200 | $167.81 | $33.6K Sale | Form 4 ↗ |
| Nov 10, 2026 | Jeffrey S. Martini Chief Scientific Officer | PVLA Palvella Therapeutics, Inc. | Sale | 1,500 | $166.91 | $250.4K Sale | Form 4 ↗ |
| Nov 10, 2026 | Jeffrey S. Martini Chief Scientific Officer | PVLA Palvella Therapeutics, Inc. | Sale | 1,651 | $165.85 | $273.8K Sale | Form 4 ↗ |
| Nov 10, 2026 | Jeffrey S. Martini Chief Scientific Officer | PVLA Palvella Therapeutics, Inc. | Sale | 1,449 | $164.85 | $238.9K Sale | Form 4 ↗ |
| Nov 10, 2026 | Jeffrey S. Martini Chief Scientific Officer | PVLA Palvella Therapeutics, Inc. | Sale | 100 | $163.34 | $16.3K Sale | Form 4 ↗ |
| Oct 21, 2026 | Kathleen Goin Chief Operating Officer | PVLA Palvella Therapeutics, Inc. | Sale | 607 | $126.19 | $76.6K Sale | Form 4 ↗ |
| Oct 21, 2026 | Kathleen Goin Chief Operating Officer | PVLA Palvella Therapeutics, Inc. | Sale | 1,663 | $125.16 | $208.1K Sale | Form 4 ↗ |
| Oct 21, 2026 | Kathleen Goin Chief Operating Officer | PVLA Palvella Therapeutics, Inc. | Sale | 2,043 | $123.62 | $252.6K Sale | Form 4 ↗ |
| Sep 16, 2026 | Kathleen Goin Chief Operating Officer | PVLA Palvella Therapeutics, Inc. | Sale | 1,654 | $153.24 | $253.5K Sale | Form 4 ↗ |
| Sep 16, 2026 | Kathleen Goin Chief Operating Officer | PVLA Palvella Therapeutics, Inc. | Sale | 989 | $152.36 | $150.7K Sale | Form 4 ↗ |
| Sep 16, 2026 | Kathleen Goin Chief Operating Officer | PVLA Palvella Therapeutics, Inc. | Sale | 1,659 | $151.16 | $250.8K Sale | Form 4 ↗ |
| Sep 15, 2026 | George M. Jenkins Director | PVLA Palvella Therapeutics, Inc. | Sale | 560 | $151.33 | $84.7K Sale | Form 4 ↗ |
| Sep 15, 2026 | George M. Jenkins Director | PVLA Palvella Therapeutics, Inc. | Sale | 263 | $150.40 | $39.6K Sale | Form 4 ↗ |
| Sep 15, 2026 | George M. Jenkins Director | PVLA Palvella Therapeutics, Inc. | Sale | 954 | $149.38 | $142.5K Sale | Form 4 ↗ |
| Sep 14, 2026 | George M. Jenkins Director | PVLA Palvella Therapeutics, Inc. | Sale | 1,560 | $153.10 | $238.8K Sale | Form 4 ↗ |
| Sep 14, 2026 | George M. Jenkins Director | PVLA Palvella Therapeutics, Inc. | Sale | 6,160 | $152.12 | $937.1K Sale | Form 4 ↗ |
| Sep 14, 2026 | George M. Jenkins Director | PVLA Palvella Therapeutics, Inc. | Sale | 5,632 | $151.46 | $853.0K Sale | Form 4 ↗ |
| Sep 11, 2026 | George M. Jenkins Director | PVLA Palvella Therapeutics, Inc. | Sale | 1,274 | $153.06 | $195.0K Sale | Form 4 ↗ |
| Sep 11, 2026 | George M. Jenkins Director | PVLA Palvella Therapeutics, Inc. | Sale | 4,577 | $151.72 | $694.4K Sale | Form 4 ↗ |
| Sep 11, 2026 | George M. Jenkins Director | PVLA Palvella Therapeutics, Inc. | Sale | 6,520 | $150.62 | $982.0K Sale | Form 4 ↗ |
| Sep 2, 2026 | Christopher P. Kiritsy Director | PVLA Palvella Therapeutics, Inc. | Sale | 313 | $157.00 | $49.1K Sale | Form 4 ↗ |
| Aug 19, 2026 | Kathleen Goin Chief Operating Officer | PVLA Palvella Therapeutics, Inc. | Sale | 302 | $156.77 | $47.3K Sale | Form 4 ↗ |
| Aug 19, 2026 | Kathleen Goin Chief Operating Officer | PVLA Palvella Therapeutics, Inc. | Sale | 102 | $155.59 | $15.9K Sale | Form 4 ↗ |
| Aug 19, 2026 | Kathleen Goin Chief Operating Officer | PVLA Palvella Therapeutics, Inc. | Sale | 400 | $153.00 | $61.2K Sale | Form 4 ↗ |
| Aug 19, 2026 | Kathleen Goin Chief Operating Officer | PVLA Palvella Therapeutics, Inc. | Sale | 1,998 | $151.80 | $303.3K Sale | Form 4 ↗ |
| Aug 19, 2026 | Kathleen Goin Chief Operating Officer | PVLA Palvella Therapeutics, Inc. | Sale | 1,500 | $151.39 | $227.1K Sale | Form 4 ↗ |
| Jul 15, 2026 | Kathleen Goin Chief Operating Officer | PVLA Palvella Therapeutics, Inc. | Sale | 1,911 | $150.25 | $287.1K Sale | Form 4 ↗ |
| Jul 15, 2026 | Kathleen Goin Chief Operating Officer | PVLA Palvella Therapeutics, Inc. | Sale | 1,029 | $149.27 | $153.6K Sale | Form 4 ↗ |
| Jul 15, 2026 | Kathleen Goin Chief Operating Officer | PVLA Palvella Therapeutics, Inc. | Sale | 840 | $148.40 | $124.7K Sale | Form 4 ↗ |
| Jul 15, 2026 | Kathleen Goin Chief Operating Officer | PVLA Palvella Therapeutics, Inc. | Sale | 522 | $147.14 | $76.8K Sale | Form 4 ↗ |
| Jun 17, 2026 | Kathleen Goin Chief Operating Officer | PVLA Palvella Therapeutics, Inc. | Sale | 25 | $112.23 | $2,806 Sale | Form 4 ↗ |
| Jun 17, 2026 | Kathleen Goin Chief Operating Officer | PVLA Palvella Therapeutics, Inc. | Sale | 1,887 | $111.31 | $210.0K Sale | Form 4 ↗ |
| Jun 17, 2026 | Kathleen Goin Chief Operating Officer | PVLA Palvella Therapeutics, Inc. | Sale | 2,390 | $110.26 | $263.5K Sale | Form 4 ↗ |
| May 20, 2026 | Kathleen Goin Chief Operating Officer | PVLA Palvella Therapeutics, Inc. | Sale | 48 | $111.90 | $5,371 Sale | Form 4 ↗ |
| May 20, 2026 | Kathleen Goin Chief Operating Officer | PVLA Palvella Therapeutics, Inc. | Sale | 891 | $111.30 | $99.2K Sale | Form 4 ↗ |
| May 20, 2026 | Kathleen Goin Chief Operating Officer | PVLA Palvella Therapeutics, Inc. | Sale | 3,363 | $110.35 | $371.1K Sale | Form 4 ↗ |
| Apr 15, 2026 | Kathleen Goin Chief Operating Officer | PVLA Palvella Therapeutics, Inc. | Sale | 100 | $130.33 | $13.0K Sale | Form 4 ↗ |
| Apr 15, 2026 | Kathleen Goin Chief Operating Officer | PVLA Palvella Therapeutics, Inc. | Sale | 639 | $129.17 | $82.5K Sale | Form 4 ↗ |
| Apr 15, 2026 | Kathleen Goin Chief Operating Officer | PVLA Palvella Therapeutics, Inc. | Sale | 561 | $128.23 | $71.9K Sale | Form 4 ↗ |
| Apr 15, 2026 | Kathleen Goin Chief Operating Officer | PVLA Palvella Therapeutics, Inc. | Sale | 1,500 | $127.13 | $190.7K Sale | Form 4 ↗ |
| Apr 15, 2026 | Kathleen Goin Chief Operating Officer | PVLA Palvella Therapeutics, Inc. | Sale | 1,502 | $125.96 | $189.2K Sale | Form 4 ↗ |
| Mar 30, 2026 | George M. Jenkins Director | PVLA Palvella Therapeutics, Inc. | Buy | 445 | $112.30 | $50.0K Buy | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:55 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances